US Stocks
/
Avalo Therapeutics, Inc. Share Price
Avalo Therapeutics, Inc. Share Price

Avalo Therapeutics, Inc. Share Price

NASDAQ: AVTX | Micro Cap
$13.64
+$0.19 (1.41%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Avalo Therapeutics, Inc. Stock Performance

Open
$13.45
Prev. Close
$13.46
Circuit Range
N/A
Day Range
$13.45 - $13.78
Year Range
$12.55 - $24.23
Volume
41,324
Average Traded
$13.64

Avalo Therapeutics, Inc. Share Price Today

As of 10 October 2026, Avalo Therapeutics, Inc.'s share price is $13.64. The stock opened at $13.45, compared to its previous close of $13.46. During today's trading session, Avalo Therapeutics, Inc.'s share price traded between $13.45 and $13.78, with an average price of $13.61. Over the past 52 weeks, the stock has recorded a high of $24.23 and a low of $12.55. In terms of performance, Avalo Therapeutics, Inc.'s share price has risen by 1.75% over the last six months and is down 23.34% on a year-on-year basis.

Avalo Therapeutics, Inc. Share Price Chart

$13.45$13.78
L
Show Current Price
H

Avalo Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$182.91M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.87
Revenue (TTM)
$60.00M
Return On Equity (TTM)
-22.36%
Profit Margin
-130433.33%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-18.71%

Avalo Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.06$0.00$0.00
Net Profit-$30.63-$13.72-$19.63-$36.36
Net Profit MarginN/A-22866.67%N/AN/A
Income ChangeN/A55.21%-43.08%-85.23%

Avalo Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$18.05$1.92$0.44$0.06
Net Profit-$41.66-$31.54-$35.13-$78.26
Net Profit Margin-230.80%-1642.71%-7984.09%-130433.33%
Income ChangeN/A24.29%-11.38%-122.77%

About Avalo Therapeutics, Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Avalo Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$15.38
$13.64
-11.08%
Sep 2026
$19.64
$15.34
-23.51%
Aug 2026
$18.07
$20.05
+9.89%
Jul 2026
$18.64
$18.25
-1.19%
Jun 2026
$15.90
$18.47
+15.94%
May 2026
$13.43
$15.93
+18.79%
Apr 2026
$15.10
$13.41
-10.72%
Mar 2026
$16.91
$15.02
-14.56%
Feb 2026
$15.78
$17.58
+16.23%
Jan 2026
$17.75
$15.13
-16.64%
Dec 2025
$18.50
$18.14
-4.85%
Nov 2025
$18.03
$19.07
+7.13%

AVTX Share Price FAQs

What is Avalo Therapeutics, Inc. share price today?

chevron-up
Avalo Therapeutics, Inc. share price today is $13.64 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Avalo Therapeutics, Inc. stock?

chevron-up
The 52 week high of Avalo Therapeutics, Inc. stock is $24.23, while the 52 week low is $12.55 as of 10 Oct '26.

What is AVTX's market capitalisation today?

chevron-up
AVTX market capitalisation is $182.91M as of October 10, 2026, at 3:00 am IST.

What is AVTX's net income for the last quarter?

chevron-up
AVTX's net income for the last quarter is -36.36B USD.

What is the 5 year returns of AVTX?

chevron-up
The 5 year returns of AVTX is -99.80% as on 10 Oct '26.

What is the high & low stock price of AVTX today?

chevron-up
AVTX stock price hit a high of $13.78 and low of $13.45 as of 10 Oct '26.

Can I buy AVTX shares in India?

chevron-up
Yes. You can buy AVTX in India by opening an international trading account.